Company News

Atrandi Launches Proof-of-Concept Program for High-Throughput Single-Cell Microbial DNA Sequencing
Atrandi Biosciences Launches Proof-of-Concept Program for High-Throughput Single-Cell Microbial DNA Sequencing VILNIUS, Lithuania | February 2024 – Atrandi Biosciences has recently unveiled the Flux microfluidic system and the Single-Microbe DNA...
Atrandi and Bigelow SCGC collaborate on bioinformatics services
Atrandi Biosciences and Bigelow Laboratory's Single Cell Genomics Center (SCGC) have teamed up to complement the high-throughput single-cell microbial DNA sequencing workflow with bioinformatics services VILNIUS, Lithuania and BOOTHBAY, ME, US | February...
Atrandi Unveils Transformative Single-Cell Analysis Tools for Microbial Genomics
VILNIUS, Lithuania | January 2024 – Atrandi Biosciences introduces Flux, an intuitive microfluidic platform, and the Single-Microbe DNA Barcoding Kit, supporting high-throughput microbial DNA sequencing. These innovations harness the power of Semi-Permeable...
Atrandi Biosciences and Suremedical Join Forces for South Korean Expansion
VILNIUS, Lithuania | December 2023 – Atrandi Biosciences, an innovator in microfluidic tools, is delighted to announce a strategic alliance with Suremedical Inc., a prominent distributor of scientific devices in South Korea. This collaboration marks...
Atrandi Biosciences champions microfluidics-based screening at PEGS 2023 conference in Portugal
VILNIUS, Lithuania | November 2023 – Atrandi Biosciences recently participated at the Protein & Antibody Engineering Summit (PEGS) in Portugal, showcasing advancements in droplet microfluidics and semi-permeable capsule technologies. Zana Kapustina...
Atrandi Biosciences Hosts Pre-Conference Workshop at EMBL Human Microbiome Symposium
VILNIUS, Lithuania | October 2023 – Atrandi Biosciences had a noteworthy presence at the EMBO | EMBL Symposium: The Human Microbiome, hosting an exclusive pre-conference workshop as part of the event. The workshop, led by Senior Product Manager Linas...
Atrandi Biosciences democratized SPC generation by launching a push-button microfluidic platform
VILNIUS, Lithuania | September 2023 – Atrandi Biosciences democratized SPC generation by launching a push-button microfluidic platform The Flux platform introduces a seamless parallelization capability, enabling simultaneous processing of up to 8
Atrandi Biosciences and DTU Enter Collaboration for Microbial Research Advancements
VILNIUS, Lithuania | August 2023 – Atrandi Biosciences is delighted to announce a strategic collaboration with the Technical University of Denmark's (DTU) National Food Institute, representing a significant stride in advancing microbial research
Atrandi Bio Expands Global Reach with Exclusive Distribution Partnership with 9X Bio in China
VILNIUS, Lithuania | July 2023 – Atrandi Bio, a leading provider of microfluidic solutions, has joined forces with 9X Bio, a well-established distributor in China, to solidify an exclusive distribution agreement. This collaboration marks a significant...
Presenting in BaGeCo with collaborator Meilee Ling
VILNIUS, Lithuania | June 2023 – Atrandi Biosciences Spotlights AMR Breakthroughs with Dr. Meilee Ling's (DTU) Presentation at BaGeCo 2023 Symposium Atrandi Biosciences participated in the 16th Symposium on Bacterial Genetics and Ecology (BaGeCo...
Atrandi Biosciences Secures Exclusive Distribution Partnership with BIOKÉ for BeNeLux Region
VILNIUS, Lithuania | May 2023 – Atrandi Biosciences, formerly known as Droplet Genomics, proudly announces a strategic distribution partnership with BIOKÉ for the BeNeLux region (Belgium, Netherlands, and Luxembourg). This collaboration marks a pivotal...
Atrandi Biosciences launches a new semi-permeable capsule kit
VILNIUS, Lithuania | April 2023 – Atrandi Biosciences, an emerging developer of innovative microfluidic solutions for the life sciences, is thrilled to announce the release of its groundbreaking Semi-Permeable Capsule (SPC) technology through the
Atrandi Biosciences Secures Funding
VILNIUS, Lithuania | March 2023 – Atrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technology VILNIUS, Lithuania and DENVER, CO, March 23, 2023 - Backed by international investors, Atrandi
Droplet Genomics Appoints Andy Watson as Board Chair
VILNIUS, Lithuania | February 14, 2023 – Droplet Genomics, an emerging innovator and provider of microfluidic and single cell analysis technologies, announced today the appointment of Andy Watson as its Chairman of the Board of Directors. “We are...
LabGene and Droplet Genomics Join Forces to Accelerate Microfluidic Discoveries in Switzerland
VILNIUS, Lithuania | March 2023 – Droplet Genomics, a leading provider of innovative microfluidic solutions, is excited to announce that it has signed Labgene as its new distributor in Switzerland. This collaboration between two industry leaders will...
Exhibiting at the Festival of Genomics & Biodata
Dear Attendees, We are pleased to inform you that we will be participating in The Festival of Genomics & Biodata, to be held on January 25-26 at the Business Design Centre. Our booth, number TT8, will be located in the foyer outside the Main Stage and...